- Home
- XTLB vs LIQT Comparison
XTLB vs LIQT Comparison
Compare XTLB & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTLB
- LIQT
- Stock Information
- Founded
- XTLB 1993
- LIQT 2004
- Country
- XTLB Israel
- LIQT Denmark
- Employees
- XTLB N/A
- LIQT N/A
- Industry
- XTLB Biotechnology: Pharmaceutical Preparations
- LIQT Industrial Machinery/Components
- Sector
- XTLB Health Care
- LIQT Technology
- Exchange
- XTLB Nasdaq
- LIQT Nasdaq
- Market Cap
- XTLB 12.8M
- LIQT 15.8M
- IPO Year
- XTLB 2005
- LIQT N/A
- Fundamental
- Price
- XTLB $2.17
- LIQT $2.22
- Analyst Decision
- XTLB
- LIQT Strong Buy
- Analyst Count
- XTLB 0
- LIQT 2
- Target Price
- XTLB N/A
- LIQT $7.08
- AVG Volume (30 Days)
- XTLB 5.2K
- LIQT 8.6K
- Earning Date
- XTLB 11-20-2024
- LIQT 11-07-2024
- Dividend Yield
- XTLB N/A
- LIQT N/A
- EPS Growth
- XTLB N/A
- LIQT N/A
- EPS
- XTLB N/A
- LIQT N/A
- Revenue
- XTLB N/A
- LIQT $17,720,520.00
- Revenue This Year
- XTLB N/A
- LIQT $5.96
- Revenue Next Year
- XTLB N/A
- LIQT $32.89
- P/E Ratio
- XTLB N/A
- LIQT N/A
- Revenue Growth
- XTLB N/A
- LIQT 8.53
- 52 Week Low
- XTLB $0.75
- LIQT $1.90
- 52 Week High
- XTLB $4.99
- LIQT $4.10
- Technical
- Relative Strength Index (RSI)
- XTLB 31.89
- LIQT 36.31
- Support Level
- XTLB $2.13
- LIQT $2.26
- Resistance Level
- XTLB $2.56
- LIQT $2.51
- Average True Range (ATR)
- XTLB 0.10
- LIQT 0.15
- MACD
- XTLB -0.03
- LIQT -0.08
- Stochastic Oscillator
- XTLB 8.70
- LIQT 7.01
About XTLB XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.